Relmada Therapeutics updates corporate presentation on October 4, 2023

RELMADA THERAPEUTICS, INC.

Filed updated corporate presentation under Item 8.01; no financial or pipeline data disclosed.
Presentation titled 'Targeting Major Advances in the Treatment of CNS Disorders'.
No material changes or specific business updates provided in the filing or exhibit.

item 8.01 item 9.01

RELMADA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001013762-23-001391

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.